APA (7th ed.) Citation

Rezan Topaloğlu, Bora Gülhan, Kübra Çelegen, Mihriban İnözü, Mutlu Hayran, Ali Düzova, . . . Fatih Ozaltin. (2019). Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Rezan Topaloğlu, Bora Gülhan, Kübra Çelegen, Mihriban İnözü, Mutlu Hayran, Ali Düzova, Fatih Ozaltin, Fatih Ozaltin, and Fatih Ozaltin. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Rezan Topaloğlu, et al. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. Frontiers Media S.A., 2019.